First Light Acquisition Group, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was USD 3.53 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +10.55% |
|
+7.96% | -88.41% |
07-08 | Calidi Biotherapeutics, Inc. Enters into A Certain Loan Agreement with Dennis R. Conklin | CI |
07-05 | Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.41% | 11.23M | |
+20.63% | 127B | |
+23.21% | 117B | |
+25.68% | 27.67B | |
-20.17% | 20.33B | |
-17.08% | 16.79B | |
-18.07% | 15.63B | |
+11.92% | 14.84B | |
-47.70% | 14.65B | |
+58.32% | 14.43B |
- Stock Market
- Equities
- CLDI Stock
- News CALI BIOTPAR
- First Light Acquisition Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022